ReP USP - Resultado da busca

Artigo de periodico
Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection (2014)
Weg, Cornelia A. M. van de; Pannuti, Cláudio S.; Ham, Henk-Jan van den; Araújo, Evaldo S. A. de; Boas, Lucy S. V.; Felix, Alvina C.; Carvalho, Karina I.; Lev, José E.; Romano, Camila M.; Centrone, Cristiane C.; Rodrigues, Celia L. de Lima; Luna, Expedito José de Albuquerque; Gorpa, Eric C. M. van; Osterhaus, Albert D. M. E.; Kallas, Esper G.; Martina, Byron E. E.
Source: Journal of Clinical Virology. Unidades: FM, IMT
Subjects: VÍRUS DA DENGUE, BIOMARCADORES, TESTES SOROLÓGICOS, ANTAGONISTAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEG, Cornelia A. M. van de et al. Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection. Journal of Clinical Virology, v. 60, n. 4, p. 328-335, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jcv.2014.05.001. Acesso em: 09 nov. 2024.
APA
Weg, C. A. M. van de, Pannuti, C. S., Ham, H. -J. van den, Araújo, E. S. A. de, Boas, L. S. V., Felix, A. C., et al. (2014). Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection. Journal of Clinical Virology, 60( 4), 328-335. doi:10.1016/j.jcv.2014.05.001
NLM
Weg CAM van de, Pannuti CS, Ham H-J van den, Araújo ESA de, Boas LSV, Felix AC, Carvalho KI, Lev JE, Romano CM, Centrone CC, Rodrigues CL de L, Luna EJ de A, Gorpa ECM van, Osterhaus ADME, Kallas EG, Martina BEE. Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection [Internet]. Journal of Clinical Virology. 2014 ; 60( 4): 328-335.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.jcv.2014.05.001
Vancouver
Weg CAM van de, Pannuti CS, Ham H-J van den, Araújo ESA de, Boas LSV, Felix AC, Carvalho KI, Lev JE, Romano CM, Centrone CC, Rodrigues CL de L, Luna EJ de A, Gorpa ECM van, Osterhaus ADME, Kallas EG, Martina BEE. Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection [Internet]. Journal of Clinical Virology. 2014 ; 60( 4): 328-335.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.jcv.2014.05.001
Artigo de periodico
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository (2014)
Kassanjee, Reshma; Pilcher, Christopher D.; Keating, Sheila M.; Facente, Shelley N.; McKinney, Elaine; Price, Matthew A.; Martin, Jeffrey N.; Little, Susan; Hecht, Frederick M.; Kallas, Esper G.; Welte, Alex; Busch, Michael P.; Murphy, Gary
Source: AIDS. Unidade: FM
Subjects: HIV, INFECÇÕES POR HIV (INCIDÊNCIA), BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KASSANJEE, Reshma et al. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS, v. 28, n. 16, p. 2439-2449, 2014Tradução . . Disponível em: https://doi.org/10.1097/QAD.0000000000000429. Acesso em: 09 nov. 2024.
APA
Kassanjee, R., Pilcher, C. D., Keating, S. M., Facente, S. N., McKinney, E., Price, M. A., et al. (2014). Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS, 28( 16), 2439-2449. doi:10.1097/QAD.0000000000000429
NLM
Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, Martin JN, Little S, Hecht FM, Kallas EG, Welte A, Busch MP, Murphy G. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository [Internet]. AIDS. 2014 ; 28( 16): 2439-2449.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1097/QAD.0000000000000429
Vancouver
Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, Martin JN, Little S, Hecht FM, Kallas EG, Welte A, Busch MP, Murphy G. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository [Internet]. AIDS. 2014 ; 28( 16): 2439-2449.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1097/QAD.0000000000000429
Artigo de periodico
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis (2014)
Solomon, Marc M.; Lama, Javier R.; Glidden, David V.; Mulligan, Kathleen; McMahan, Vanessa; Liu, Albert Y.; Guanira, Juan Vicente; Veloso, Valdilea G.; Mayer, Kenneth H.; Chariyalertsak, Suwath; Schechter, Mauro; Bekker, Linda-Gail; Kallás, Esper Georges; Burns, David N.; Grant, Robert M.
Source: AIDS. Unidade: FM
Subjects: HIV (PREVENÇÃO E CONTROLE), RIM, FÁRMACOS IMUNOSSUPRESSORES, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOLOMON, Marc M. et al. Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS, v. 28, n. 6, p. 851-859, 2014Tradução . . Disponível em: https://doi.org/10.1097/QAD.0000000000000156. Acesso em: 09 nov. 2024.
APA
Solomon, M. M., Lama, J. R., Glidden, D. V., Mulligan, K., McMahan, V., Liu, A. Y., et al. (2014). Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS, 28( 6), 851-859. doi:10.1097/QAD.0000000000000156
NLM
Solomon MM, Lama JR, Glidden DV, Mulligan K, McMahan V, Liu AY, Guanira JV, Veloso VG, Mayer KH, Chariyalertsak S, Schechter M, Bekker L-G, Kallás EG, Burns DN, Grant RM. Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis [Internet]. AIDS. 2014 ; 28( 6): 851-859.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1097/QAD.0000000000000156
Vancouver
Solomon MM, Lama JR, Glidden DV, Mulligan K, McMahan V, Liu AY, Guanira JV, Veloso VG, Mayer KH, Chariyalertsak S, Schechter M, Bekker L-G, Kallás EG, Burns DN, Grant RM. Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis [Internet]. AIDS. 2014 ; 28( 6): 851-859.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1097/QAD.0000000000000156

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em